Myriota expands IoT reach into Canada

Nanosatellite developer Myriota has extended its reach in the Canadian market with the purchase of satellite communications assets from exactEarth Ltd. The acquisition will see Myriota Canada acquire four satellites, a global network of ground station assets, and their associated spectrum licenses. The acquisition will increase the Adelaide company’s capability to deliver low-cost, low-power, secure…

Drug companies should drop their patents and collaborate to fight coronavirus

As the coronavirus pandemic continues to claim victims around the world, the race is on to produce the right medicines to fight it. This includes developing a vaccine to stop people from falling ill in the first place, testing kits and drugs to treat those that fall ill with COVID-19.

Noxopharm investigates Covid-19 treatment

Drug developer Noxopharm is following up on indications that an experimental anti-cancer drug may be effective against the Covid-19 coronavirus. Melbourne’s Hudson Institute of Medical Research has identified anti-inflammatory properties of the experimental drug idronoxil, the active ingredient in the company’s anti-cancer drug candidate Veyonda. Pre-clinical models indicate the drug has the ability to treat…

Titomic in new US defence tie-up

Large-scale additive manufacturing technology company Titomic has linked up with US defence R&D company Triton Systems to validate its Titomic Kinetic Fusion (TKF) technology for US defence projects. The two companies have entered a strategic partnership which aims to develop innovative products and solutions under US defence department grant schemes – the department spends US$60…